Fersi
ActiveSummary
Fersi has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €745,342 and a net result of €143,512. Equity is growing by ~16.5% per year across the filed fiscal years. Its solvency ranks better than 70% of 16718 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability88▼-8
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €60,000 at 30 days acceptable
Liquidity ample (current ratio 58.03 against 14.35 in 2024; short-term debt: 1.6% and cash: 6.2% of total assets), and 19% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
81%
Return on assets
15.6%
Age of the figures
16 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-05-2025 was due by 31-12-2025 and was filed on 30-12-2025, 1 day ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
1 d early
2024
13 d late
2023
4 d early
2022
2 d early
2021
4 d early
2020
2 d early
2019
32 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 5 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-05-2026 and is due by 31-12-2026. Nothing is late today.
Companies Code · seven monthsPosition in the running window
31-05-2026 close27-09-2026 today31-12-2026 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
In the rankings
#4 oldest company in Boom, Health and social work sector#7 company by total assets in Boom, Health and social work sector#7 company by equity in Boom, Health and social work sector
Equity
€745,342▲ 16.5%
2024 · €639,632
Total assets
€919,896▲ 8.0%
2024 · €851,872
Net result
€143,512▼ 23.6%
2024 · €187,813
Working capital
€833,481▲ 19.4%
2024 · €698,193
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€125,596▲ 47.1%€171,022▲ 36.2%€177,220▲ 3.6%€242,664▲ 36.9%€143,739▼ 40.8%
Net result€87,493within the sector's middle half▲ 36.2%€121,892above the sector's middle half▲ 39.3%€125,996above the sector's middle half▲ 3.4%€187,813above the sector's middle half▲ 49.1%€143,512above the sector's middle half▼ 23.6%
Equity€435,604above the sector's middle half▲ 25.1%€450,574above the sector's middle half▲ 3.4%€491,950above the sector's middle half▲ 9.2%€639,632above the sector's middle half▲ 30.0%€745,342above the sector's middle half▲ 16.5%
Total assets€644,766above the sector's middle half▲ 12.2%€656,134above the sector's middle half▲ 1.8%€725,343above the sector's middle half▲ 10.5%€851,872above the sector's middle half▲ 17.4%€919,896above the sector's middle half▲ 8.0%
Debt€49,222▼ 25.9%€45,621▼ 7.3%€73,453▲ 61.0%€52,300▼ 28.8%€14,615▼ 72.1%
Working capital€496,612▲ 32.9%€532,109▲ 7.1%€577,812▲ 8.6%€698,193▲ 20.8%€833,481▲ 19.4%
Solvency67.6%within the sector's middle half▲ 7.0pp68.7%within the sector's middle half▲ 1.1pp67.8%within the sector's middle half▼ 0.8pp75.1%within the sector's middle half▲ 7.3pp81.0%within the sector's middle half▲ 5.9pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 41% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €919,896
Fixed assets
€71,800 ▼ 29.2%
Current assets
€848,096 ▲ 13.0%
Equity and liabilities €919,896
Equity
€745,342 ▲ 16.5%
Provisions
€159,940 =
Debt
€14,615 ▼ 72.1%
Debt's share of the balance-sheet total falls from 6.1% to 1.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€173,318▼
2024 · €272,138
Cash flow
€173,091▼
2024 · €217,287
Current ratio
58.03▲
2024 · 14.35
Debt to equity
0.02▼
2024 · 0.08
ROE
19.3%▼
2024 · 29.4%
ROA
15.6%▼
2024 · 22.0%
Interest coverage
22.46▼
2024 · 204.33
Debt ≤ 1 year
€14,615▼
2024 · €52,300
Income taxes
€62,959▼
2024 · €83,307
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 20,082 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 95% are still going.
- Small
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.2%
went bankrupt
4.7%
stopped otherwise
95%
still going
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.6% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 20,082 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | €38,380 | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €45,436 | €25,186 | €25,440 | €29,474 | €29,579 | ▲ 0.4% |
| Other operating charges640/8 | - | €2,032 | €2,207 | €2,406 | €2,457 | ▲ 2.1% |
| Gross operating margin9900 | €173,000 | €198,240 | €204,867 | €274,544 | €175,775 | ▼ 36.0% |
| Operating profit (loss)9901 | €125,596 | €171,022 | €177,220 | €242,664 | €143,739 | ▼ 40.8% |
| Financial income75/76B | - | €3,994 | €2,895 | €29,787 | €70,451 | ▲ 137% |
| Recurring financial income75 | €5,892 | €3,994 | €2,895 | €29,787 | €70,451 | ▲ 137% |
| Financial charges65/66B | - | €433 | €171 | €1,332 | €7,718 | ▲ 479% |
| Recurring financial charges65 | €5,596 | €433 | €171 | €1,332 | €7,718 | ▲ 479% |
| Profit (loss) for the period before taxes9903 | €125,892 | €174,583 | €179,945 | €271,119 | €206,472 | ▼ 23.8% |
| Income taxes67/77 | €38,399 | €52,691 | €53,949 | €83,307 | €62,959 | ▼ 24.4% |
| Profit (loss) for the period9904 | €87,493 | €121,892 | €125,996 | €187,813 | €143,512 | ▼ 23.6% |
| Profit (loss) for the period to be appropriated9905 | €87,493 | €121,892 | €125,996 | €187,813 | €143,512 | ▼ 23.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €644,766 | €656,134 | €725,343 | €851,872 | €919,896 | ▲ 8.0% |
| Fixed assets21/28 | €98,932 | €78,405 | €74,078 | €101,379 | €71,800 | ▼ 29.2% |
| Tangible fixed assets22/27 | €98,932 | €78,405 | €74,078 | €101,379 | €71,800 | ▼ 29.2% |
| Land and buildings22 | - | €14,812 | €13,652 | €10,274 | €6,953 | ▼ 32.3% |
| Plant, machinery and equipment23 | - | €3,726 | €5,838 | €4,954 | €2,992 | ▼ 39.6% |
| Furniture and vehicles24 | - | €646 | - | €45,069 | €34,054 | ▼ 24.4% |
| Other tangible fixed assets26 | - | €59,222 | €54,588 | €41,081 | €27,801 | ▼ 32.3% |
| Current assets29/58 | €545,834 | €577,729 | €651,265 | €750,493 | €848,096 | ▲ 13.0% |
| Amounts receivable within one year40/41 | €205,349 | €142,500 | €104,500 | €135,500 | €189,000 | ▲ 39.5% |
| Trade receivables40 | - | - | €500 | - | - | - |
| Other amounts receivable41 | - | €142,500 | €104,000 | €135,500 | €189,000 | ▲ 39.5% |
| Current investments50/53 | €212,542 | €293,062 | €293,062 | €474,401 | €582,910 | ▲ 22.9% |
| Cash at bank and in hand54/58 | €28,616 | €35,887 | €131,975 | €20,558 | €56,679 | ▲ 176% |
| Deferred charges and accrued income490/1 | - | €106,280 | €121,727 | €120,035 | €19,508 | ▼ 83.7% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €644,766 | €656,134 | €725,343 | €851,872 | €919,896 | ▲ 8.0% |
| Equity10/15 | €435,604 | €450,574 | €491,950 | €639,632 | €745,342 | ▲ 16.5% |
| Contributions10/11 | - | €12,500 | €12,500 | €14,375 | €14,375 | = |
| Reserves13 | €423,104 | €438,074 | €479,450 | €625,257 | €730,967 | ▲ 16.9% |
| Non-distributable reserves130/1 | - | €1,875 | €1,875 | - | - | - |
| Reserves not available under the articles1311 | - | €1,875 | €1,875 | - | - | - |
| Distributable reserves133 | - | €436,199 | €477,575 | €625,257 | €730,967 | ▲ 16.9% |
| Provisions and deferred taxes16 | €159,940 | €159,940 | €159,940 | €159,940 | €159,940 | = |
| Provisions for liabilities and charges160/5 | - | €159,940 | €159,940 | €159,940 | €159,940 | = |
| Pensions and similar obligations160 | - | €159,940 | €159,940 | €159,940 | €159,940 | = |
| Amounts payable17/49 | €49,222 | €45,621 | €73,453 | €52,300 | €14,615 | ▼ 72.1% |
| Amounts payable within one year42/48 | €49,222 | €45,621 | €73,453 | €52,300 | €14,615 | ▼ 72.1% |
| Trade debts44 | €3,342 | €10,163 | €44,326 | €7,404 | €7,153 | ▼ 3.4% |
| Suppliers440/4 | - | €10,163 | €44,326 | €7,404 | €7,153 | ▼ 3.4% |
| Taxes, remuneration and social security45 | - | €34,691 | €28,948 | €42,824 | €4,571 | ▼ 89.3% |
| Taxes450/3 | - | €34,691 | €28,948 | €42,824 | €4,571 | ▼ 89.3% |
| Other amounts payable47/48 | - | €767 | €178 | €2,073 | €2,891 | ▲ 39.5% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €87,493 | €121,892 | €125,996 | €187,813 | €143,512 | ▼ 23.6% |
| + Depreciation and write-downs630 | €45,436 | €25,186 | €25,440 | €29,474 | €29,579 | ▲ 0.4% |
| Operating cash flow (approximation) | €132,929 | €147,077 | €151,436 | €217,287 | €173,091 | ▼ 20.3% |
| Investment in fixed assets (approximation) | - | -€4,659 | -€21,112 | -€56,775 | €0 | ▲ 100% |
| Change in cash | - | €7,271 | €96,088 | -€111,418 | €36,121 | ▲ 132% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
30-12
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
31-05
Financial
Liquidity quadruplescurrent ratio 58.03
Current ratio from 14.35 to 58.03; short-term debt falls from €52,300 to €14,615.
13-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 13 days late
2024
31-05
Financial
Highest result since 2019net €187,813 ▲49.1%
Operating result €242,664, net result €187,813, both a record.
31-05
Financial
Equity above €500,000Eq €639,632 ▲30%
6 profitable years in a row build equity to €639,632.
2023
27-12
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2022
29-12
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2021
27-12
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2020
29-12
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2019
29-11
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2018
10-12
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2017
08-12
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2016
30-11
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Boom
Ground area
810 m²
Building footprint
178 m²
Volume, LiDAR
1,289 m³
Parcel 11622C0120/00Z002, Flanders · tallest building 11.2 m, ±3 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11622C0120/00Z002 | Flanders | 810 m² | 1 · 178 m² | 11.2 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
9676001ZIF4BQD7A1M50
Similar companies · same sector, comparable size
BENOIT DEFALQUE
BE 0894.496.683
Court-Saint-Etienne · Eq €745,072
Dokter Providas
BE 0823.391.824
Wemmel · Eq €744,135
MAISON MEDICALE CUREGHEM
BE 0785.854.111
Anderlecht · Eq €747,039
Docteur BENOIT Arnaud
BE 0734.450.940
Bastogne · Eq €743,510
Huisarts Tom Jacobs
BE 0687.629.436
Antwerpen · Eq €743,176
Of 9,128 companies in sector 86210 we hold annual accounts for 6,335. 4,506 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded04-05-2001
Fiscal year end31-05
Activities, NACEBEL 2025
86210General medical practice
72101Research and development on biotechnology
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0474734628
Registered
27-03-2026
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.